Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001917012-22-000001
Filing Date
2022-05-23
Accepted
2022-05-23 12:02:33
Documents
1
Period of Report
2022-02-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 3494
  Complete submission text file 0001917012-22-000001.txt   5072
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Issuer) CIK: 0001872812 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address LEAMINGTON HOUSE 50 HARRINGTON SOUND ROAD HAMILTON PARISH D0 CR04
Business Address
Randall Diana Elizabeth (Reporting) CIK: 0001917012 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41231 | Film No.: 22950423